Published in Eur J Epidemiol on February 04, 2011
The Generation R Study: design and cohort update 2012. Eur J Epidemiol (2012) 2.84
The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56
Fetal and infant origins of asthma. Eur J Epidemiol (2012) 1.11
Associations among lung function, arterial elasticity, and circulating endothelial and inflammation markers: the multiethnic study of atherosclerosis. Hypertension (2013) 0.90
Long-term adherence to healthy dietary guidelines and chronic inflammation in the prospective Whitehall II study. Am J Med (2014) 0.86
Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study. Psychol Med (2012) 0.84
Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study. BMC Geriatr (2013) 0.83
Early origins of chronic obstructive lung diseases across the life course. Eur J Epidemiol (2014) 0.80
Inflammation as Possible Mediator for the Relationship Between Lung and Arterial Function. Lung (2015) 0.77
Dietary inflammatory index and recurrence of depressive symptoms: Results from the Whitehall II Study. Clin Psychol Sci (2016) 0.76
STROBE-ME too! Eur J Epidemiol (2011) 0.75
Association Between Average Daily Television Viewing Time and Chronic Obstructive Pulmonary Disease-Related Mortality: Findings From the Japan Collaborative Cohort Study. J Epidemiol (2015) 0.75
Small airway dysfunction in smokers with stable ischemic heart disease. PLoS One (2017) 0.75
Can apical periodontitis affect serum levels of CRP, IL-2, and IL-6 as well as induce pathological changes in remote organs? Clin Oral Investig (2015) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol (2004) 42.68
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Health inequalities among British civil servants: the Whitehall II study. Lancet (1991) 24.79
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med (2004) 15.30
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax (2004) 8.09
Cohort Profile: the Whitehall II study. Int J Epidemiol (2004) 7.63
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation (2003) 4.63
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest (2005) 4.41
A review of the healthy worker effect in occupational epidemiology. Occup Med (Lond) (1999) 4.32
Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest (2000) 3.96
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 3.69
Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia (1997) 3.34
Stress and the biology of inequality. BMJ (1997) 3.00
Systemic inflammation and COPD: the Framingham Heart Study. Chest (2007) 2.74
C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax (2005) 2.72
Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Intern Med (2004) 2.69
Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study. J Epidemiol Community Health (2003) 2.65
Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med (2003) 2.53
Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med (1997) 2.10
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax (2005) 2.08
Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax (2005) 2.03
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation (2004) 1.93
Exposure-measurement error is frequently ignored when interpreting epidemiologic study results. Eur J Epidemiol (2006) 1.93
Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.78
Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med (2006) 1.69
Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax (2007) 1.62
The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol (2000) 1.56
Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax (2004) 1.49
Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med (2006) 1.46
Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol (2008) 1.42
Alcohol and the heart in perspective. Sensible limits reaffirmed. A Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners. J R Coll Physicians Lond (1995) 1.36
Association between self-reported childhood socioeconomic position and adult lung function: findings from the British Women's Heart and Health Study. Thorax (2004) 1.31
Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med (2007) 1.25
Systemic inflammation and lung function in young adults. Thorax (2007) 1.23
Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur J Epidemiol (2007) 1.21
Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol (1999) 1.17
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol (2004) 1.09
C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol (2003) 1.09
High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J (2008) 1.03
Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax (2006) 1.03
Cytokines and the lung. Eur Respir J Suppl (2001) 0.89
Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication? Steroids (2006) 0.87
Elevated C-reactive protein: a common marker for atherosclerotic cardiovascular risk and subclinical stages of pulmonary dysfunction and osteopenia in a healthy population. Atherosclerosis (2005) 0.85
Association between asthma, asthma symptoms and C-reactive protein in US adults: data from the National Health and Nutrition Examination Survey, 1999-2002. Respirology (2007) 0.83
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet (2012) 9.43
Prediabetes: a high-risk state for diabetes development. Lancet (2012) 6.42
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ (2012) 5.26
Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension (2007) 5.20
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet (2009) 4.96
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep (2007) 4.25
Inequalities in non-communicable diseases and effective responses. Lancet (2013) 4.18
Subjective social status: its determinants and its association with measures of ill-health in the Whitehall II study. Soc Sci Med (2003) 3.79
Development: Time to leave GDP behind. Nature (2014) 3.73
Work stress in the etiology of coronary heart disease--a meta-analysis. Scand J Work Environ Health (2006) 3.64
Sickness absence as a global measure of health: evidence from mortality in the Whitehall II prospective cohort study. BMJ (2003) 3.54
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Does subjective social status predict health and change in health status better than objective status? Psychosom Med (2005) 3.15
Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study. Am J Epidemiol (2008) 3.11
Stress and cardiovascular disease. Nat Rev Cardiol (2012) 3.01
Effect of retirement on major chronic conditions and fatigue: French GAZEL occupational cohort study. BMJ (2010) 2.92
Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study. BMJ (2008) 2.80
Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality. Am J Clin Nutr (2008) 2.80
Self-rated health before and after retirement in France (GAZEL): a cohort study. Lancet (2009) 2.76
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Temporary employment and health: a review. Int J Epidemiol (2005) 2.72
The siege of Krishnapur by J. G. Farrell. Int J Epidemiol (2013) 2.67
Organizational justice: evidence of a new psychosocial predictor of health. Am J Public Health (2002) 2.67
Evidence based policy or policy based evidence? BMJ (2004) 2.59
Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ (2012) 2.56
Job strain as a risk factor for leisure-time physical inactivity: an individual-participant meta-analysis of up to 170,000 men and women: the IPD-Work Consortium. Am J Epidemiol (2012) 2.55
Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study. Lancet (2008) 2.53
Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ (2010) 2.53
Psychological distress as a risk factor for coronary heart disease in the Whitehall II Study. Int J Epidemiol (2002) 2.53
The association between self-rated health and mortality in different socioeconomic groups in the GAZEL cohort study. Int J Epidemiol (2007) 2.46
Overtime work and incident coronary heart disease: the Whitehall II prospective cohort study. Eur Heart J (2010) 2.46
Organisational downsizing, sickness absence, and mortality: 10-town prospective cohort study. BMJ (2004) 2.33
Endothelial function predicts progression of carotid intima-media thickness. Circulation (2009) 2.30
Substantial intergenerational increases in body mass index are not explained by the fetal overnutrition hypothesis: the Cardiovascular Risk in Young Finns Study. Am J Clin Nutr (2007) 2.28
Socioeconomic position, co-occurrence of behavior-related risk factors, and coronary heart disease: the Finnish Public Sector study. Am J Public Health (2007) 2.28
Dietary pattern and depressive symptoms in middle age. Br J Psychiatry (2009) 2.28
Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study. J Psychosom Res (2004) 2.26
Low workplace social capital as a predictor of depression: the Finnish Public Sector Study. Am J Epidemiol (2008) 2.22
Effect of depression onset on adherence to medication among hypertensive patients: a longitudinal modelling study. J Hypertens (2013) 2.22
Common mental disorder and obesity: insight from four repeat measures over 19 years: prospective Whitehall II cohort study. BMJ (2009) 2.19
Personality and all-cause mortality: individual-participant meta-analysis of 3,947 deaths in 76,150 adults. Am J Epidemiol (2013) 2.17
Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997-2007. Pharmacoepidemiol Drug Saf (2010) 2.12
Prospective effect of job strain on general and central obesity in the Whitehall II Study. Am J Epidemiol (2007) 2.09
Validating abbreviated measures of effort-reward imbalance at work in European cohort studies: the IPD-Work consortium. Int Arch Occup Environ Health (2013) 2.09
Excess suicides and attempted suicides in Italy attributable to the great recession. J Epidemiol Community Health (2012) 2.05
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet (2009) 2.04
Birth weight, components of height and coronary heart disease: evidence from the Whitehall II study. Int J Epidemiol (2006) 2.04
Differential associations of job control components with mortality: a cohort study, 1986-2005. Am J Epidemiol (2012) 2.03
Organisational justice and change in justice as predictors of employee health: the Whitehall II study. J Epidemiol Community Health (2004) 2.00
Work stress, smoking status, and smoking intensity: an observational study of 46,190 employees. J Epidemiol Community Health (2005) 2.00
Health behaviours, socioeconomic status, and mortality: further analyses of the British Whitehall II and the French GAZEL prospective cohorts. PLoS Med (2011) 1.99
Cause-specific mortality in old age in relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of male civil servants. Int J Epidemiol (2005) 1.98
Educational attainment but not measures of current socioeconomic circumstances are associated with leukocyte telomere length in healthy older men and women. Brain Behav Immun (2011) 1.98
Cross-sectional versus prospective associations of sleep duration with changes in relative weight and body fat distribution: the Whitehall II Study. Am J Epidemiol (2007) 1.98
Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream. PLoS Med (2008) 1.95
Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ (2012) 1.95
Prospective study of workplace social capital and depression: are vertical and horizontal components equally important? J Epidemiol Community Health (2009) 1.94
Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. J Sleep Res (2008) 1.94
Using additional information on working hours to predict coronary heart disease: a cohort study. Ann Intern Med (2011) 1.93
Socioeconomic differences in cardiometabolic factors: social causation or health-related selection? Evidence from the Whitehall II Cohort Study, 1991-2004. Am J Epidemiol (2011) 1.90
Social status and health: a comparison of British civil servants in Whitehall-II with European- and African-Americans in CARDIA. Soc Sci Med (2008) 1.89
Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol (2008) 1.88
Socioeconomic trajectories across the life course and health outcomes in midlife: evidence for the accumulation hypothesis? Int J Epidemiol (2004) 1.86
Does depression predict coronary heart disease and cerebrovascular disease equally well? The Health and Social Support Prospective Cohort Study. Int J Epidemiol (2010) 1.84
Sickness absence as a risk marker of future disability pension: the 10-town study. J Epidemiol Community Health (2004) 1.84
Comparison of alternative versions of the job demand-control scales in 17 European cohort studies: the IPD-Work consortium. BMC Public Health (2012) 1.83
Unfairness and the social gradient of metabolic syndrome in the Whitehall II Study. J Psychosom Res (2007) 1.80
An updated review of the literature: risk factors for bladder cancer with focus on occupational exposures. South Med J (2006) 1.80
Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J (2013) 1.79
Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health (2013) 1.79
Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. Eur Heart J (2011) 1.79
Perceived job insecurity as a risk factor for incident coronary heart disease: systematic review and meta-analysis. BMJ (2013) 1.78